Tumor-selective tin drug delivery published in the European Journal of Medicinal Chemistry

The paper “SBA-15 nanostructures enable tumor-selective delivery of Ph₄Sn with enhanced anticancer activity in melanoma models”, co-authored by Dr. Marko Antonijević, has been published in the European Journal of Medicinal Chemistry, vol. 316, 119020 (doi:10.1016/j.ejmech.2026.119020).

The study shows that loading tetraphenyltin into SBA-15 mesoporous silica enables tumor-selective delivery and enhances its anticancer activity in melanoma models.